AstraZeneca is a global biopharmaceutical company committed to making a difference for patients, their families, our stakeholders and society in general, through the research, development and commercialisation of innovative, new medicines.
But in today’s world of rapidly advancing science and technology, we know we cannot do it alone.
Our scientists collaborate with partners from academic institutions, governments, not-for-profit organisations, bio-techs and other pharmaceutical companies from all over the world to share skills, knowledge and resources through all stages of the R&D journey. United by our common goal -- to improve health -- we work with our partners to provide even greater focus on unmet needs and speed the delivery of the next generation of targeted, safe and effective medicines.
Videos: Collaborating with AstraZeneca
In an interview for PharmaTV, AstraZeneca’s VP Strategic Partnering and Business Development, Shaun Grady, discusses our partnering strategy at the BioPartnering Europe conference.
Martin Mackay PhD, President of Research & Development, talks about partnering with AstraZeneca.